Lifestyle Educational Program Strongly Increases Compliance to Nonpharmacologic Intervention in Hypertensive Patients: A 2-Year Follow-Up Study

Journal of Clinical Hypertension

Volumn 14, Issue 11, 2012, Pages 767-772

  Ferrara, Aldo L ^a   Pacioni, Delia ^a   Di Fronzo, Valentina ^a   Russo, Barbara F ^a   Staiano, Laura ^a   Speranza, Enza ^a   Gente, Rosaria ^a   Gargiulo, Francesco ^a   Ferrara, Fabio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRBESARTAN; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; ARTICLE; ATTITUDE TO HEALTH; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY FIBER; EDUCATION PROGRAM; FEMALE; FOLLOW UP; FOOD COMPOSITION; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LEGUME; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MOTIVATION; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT ATTITUDE; PATIENT EDUCATION; POTASSIUM INTAKE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED WINE; REINFORCEMENT; SINGLE BLIND PROCEDURE; SMOKING; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE; WAIST CIRCUMFERENCE;

ADULT; BODY WEIGHT; CHOLESTEROL; DIET, MEDITERRANEAN; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; TRIGLYCERIDES;

EID: 84868580865     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12016     Document Type: Article

References (20)

1. Lind L, Lithell H, Pollare T. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens Suppl. 1993;11:S11-S116.
2. Genest J Jr, Cohn JS. Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol. 1995;76:8A-20A.
3. Mancini M, Ferrara LA, Strazzullo P, Marotta T. Metabolic disturbances and antihypertensive therapy. J Hypertens. 1991;9(suppl 3):47-50.
4. Ferrara LA, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio study. J Hum Hypertens. 2007;21:795-801.
5. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
6. Mancia G, De Backer G, Dominiczak A, et al. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension; The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
7. Ferrara LA, Ricci F, Viola S, et al. Dietary pattern and blood pressure control in the hypertension outpatient clinic. Hypertens Res. 2007;30:1043-1050.
8. Friedewald WT, Lery RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
9. Ciccarone E, Di Castelnuovo A, Salcuni M, et al; Gendiabe Investigators. A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with type 2 diabetes. J Thromb Haemost. 2003;1:1744-1752.
10. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1990;121:293-298.
11. Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878-884.
12. The Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial. Arch Intern Med. 2010;170:1566-75.
13. Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173-1179.
14. Tsai AG, Wadden TA. Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med. 2009;24:1073-9.
15. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med. 2001;134:1-11.
16. Appel LJ, Clark JM, Yeh HC, et al; Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365:1959-1968.
17. Delahanty LM. An expanded role for dietitians in maximising retention in nutrition and lifestyle intervention trials: implications for clinical practice. J Hum Nutr Diet. 2010;23:336-343.
18. Grover AS, Lowensteyn I, Joseph L, et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. J Gen Intern Med. 2009;24:33-9.
19. Grover AS, Lowensteyn I, Joseph L, et al, for the Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy. The CHECK-UP study: a randomized controlled trial. Arch Intern Med. 2007;167:2296-2303.
20. Smith West D, Gorin AA, Subak LL, et al, for the Program to Reduce Incontinence by Diet and Exercise (PRIDE) Research Group. A motivation-focused weight loss maintenance program is an effective alternative to a skill-based approach. Int J Obes. 2011;35:259-269.